Mylan NV (NASDAQ:MYL)

41.28
Delayed Data
As of Feb 22
 +0.07 / +0.17%
Today’s Change
29.39
Today|||52-Week Range
47.82
-2.43%
Year-to-Date
Will Mylan (MYL) Disappoint Investors This Earnings Season?
Feb 22 / Zacks.com - Paid Partner Content
Novartis May Sell U.S. Generic Pill Business Amid Industry Struggles
Feb 16 / TheStreet.com - Paid Partner Content
Momenta's (MNTA) Earnings & Revenues Surpass Estimates in Q4
Feb 22 / Zacks.com - Paid Partner Content
J&J (JNJ) Gets FDA Nod for New Prostate Cancer Treatment (Revised)
Feb 16 / Zacks.com - Paid Partner Content
John Paulson Invests in Entertainment Stocks in 4th Quarter
Feb 21 / GuruFocus News - Paid Partner Content
Painkiller that once cost $138 is now $2,979
Feb 15 / CNNMoney.com
John Paulson Invests in Entertainment in 4th Quarter
Feb 20 / GuruFocus News - Paid Partner Content
J&J (JNJ) Gets FDA Nod for New Prostrate Cancer Treatment
Feb 15 / Zacks.com - Paid Partner Content
UPS's Long-Tenured Board Members Are a Red Flag for Investors
Feb 20 / TheStreet.com - Paid Partner Content
Teva Stock Falls as Novartis Brings Another Copaxone Generic
Feb 14 / Zacks.com - Paid Partner Content

Today’s Trading

Previous close41.21
Today’s open41.49
Day’s range41.06 - 42.04
Volume3,581,990
Average volume (3 months)5,809,441
Market cap$22.1B
Data as of 4:00pm ET, 02/22/2018

Growth & Valuation

Earnings growth (last year)-45.88%
Earnings growth (this year)-7.14%
Earnings growth (next 5 years)+4.90%
Revenue growth (last year)+17.44%
P/E ratio25.2
Price/Sales1.79
Price/Book1.98

Competitors

 Today’s
change
Today’s
% change
BMRNBiomarin Pharmaceuti...-0.21-0.25%
PRGOPerrigo Company PLC-0.03-0.03%
JAZZJazz Pharmaceuticals...-0.97-0.67%
ALNYAlnylam Pharmaceutic...+0.68+0.57%
Data as of 4:01pm ET, 02/22/2018

Financials

Last reporting date--
EPS forecast (this quarter)$1.41
Annual revenue (last year)$11.1B
Annual profit (last year)$480.0M
Net profit margin4.32%

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Generic
Chief Executive Officer &
Director
Heather M. Bresch
President &
Director
Rajiv Malik
Corporate headquarters
Hatfield, Hertfordshire

Forecasts